Magnesium Therapy

Magnesium Therapy Master Residency Suite

Chief Mentor: Dr. A. Narendra (Assistant Professor, Pediatrics)

MD / DNB Study Suite Interactive Learning Hub

Integrated PostGraduate Module

Therapeutic Applications of Magnesium in Pediatrics

"Postgraduates and interns, this comprehensive board splits Magnesium Therapy into discrete learning paths. Use the tabs below to toggle between high-yield exam theory blueprints, raw clinical rhythms/flowcharts, and active recall board MCQs."

— Dr. A. Narendra

Theory Long Answer Blueprint

Magnesium ($Mg^{2+}$) is the second most abundant intracellular cation and serves as a crucial cofactor in over 300 enzymatic reactions (including all reactions requiring ATP).

• Calcium Channel Blockade: Acts as a physiological calcium channel blocker, inhibiting calcium entry into smooth muscle cells, which leads to **bronchodilation and systemic vasodilation**.
• NMDA Receptor Antagonism: Blocks the N-methyl-D-aspartate (NMDA) receptor, reducing glutamate-mediated excitotoxicity. This provides substantial **neuroprotection** in hypoxic-ischemic states.
• Anti-arrhythmic Mechanism: Stabilizes myocardial cell membranes and slows down the sinus node rate, prolonging conduction time (highly useful in digitalis toxicity and Torsades).
• Inhibition of Acetylcholine: Decreases acetylcholine release at the neuromuscular junction, helping reduce skeletal muscle excitability.

1. Refractory Status Asthmaticus (Severe Acute Asthma)

Used as an adjunctive treatment when there is an inadequate response to initial aggressive therapy (nebulized $\beta_2$-agonists and systemic corticosteroids). It induces prompt bronchial smooth muscle relaxation.

2. Cardiac Arrhythmias (Torsades de Pointes)

The absolute drug of choice for polymorphic ventricular tachycardia (Torsades de Pointes) and arrhythmias secondary to digitalis toxicity or hypokalemia.

3. Severe Symptomatic Hypomagnesemia

Indicated when serum magnesium is < 1.2 mg/dL with clinical manifestations such as carpopedal spasm, tetany, tremors, hyperreflexia, or hypocalcemic seizures refractory to calcium therapy.

4. Hypertensive Crises / Acute Nephritic Syndrome

Acts as a vasodilator to help control acute hypertensive encephalopathy, particularly when secondary to glomerulonephritis.

• Antenatal Neuroprotection (Preterm Deliveries): Administered to mothers in imminent preterm labor (< 32 weeks gestation). It significantly reduces the risk of **cerebral palsy** and motor dysfunction in the surviving neonate by stabilizing neuronal membranes and dampening neuroexcitatory pathways.
• Persistent Pulmonary Hypertension of the Newborn (PPHN): Acts as a pulmonary vasodilator. When inhaled nitric oxide (iNO) is unavailable, intravenous $MgSO_4$ can be used to lower pulmonary vascular resistance, thereby improving oxygenation indexes.
• Hypoxic-Ischemic Encephalopathy (HIE): Sometimes used as adjunctive therapy in low-resource settings (not undergoing therapeutic hypothermia) to reduce NMDA-receptor mediated secondary brain injury, although close blood pressure monitoring is mandatory.

Therapeutic Serum Range: 2.0 to 4.0 mEq/L (1.5 to 2.5 mmol/L)

Clinical Signs of Toxicity

• Loss of Deep Tendon Reflexes (DTRs): First clinical sign (occurs at 4-7 mEq/L).
• Respiratory Depression: Occurs at 8-10 mEq/L due to neuromuscular blockade.
• Cardiac Conduction Blocks / Arrest: Occurs at > 12 mEq/L.
• Hypotension and flaccid muscle paralysis.

Bedside Monitoring Protocol

• Patellar Reflex (Knee Jerk): Must check before and during infusion.
• Respiratory Rate: Must monitor continuously. Hold if RR falls below age-specific norms.
• Urine Output: Magnesium is entirely renally cleared. Ensure urine output is > 1 mL/kg/hour to prevent toxic accumulation.

IMMEDIATE ANTIDOTE

10% Calcium Gluconate (0.5 to 1.0 mL/kg IV slowly over 5-10 minutes). Calcium directly antagonizes the neuromuscular and cardiac toxicity of Magnesium.

Clinical Diagrams, Algorithms & Rhythms

A Status Asthmaticus Management Integration

Clinical protocol tracking rescue escalation criteria where IV Magnesium acts as a primary bronchodilator block before mechanical ventilation steps.

B Emergency Arrhythmia: Torsades de Pointes ECG Recognition

Classical polymorphic ventricular tachycardia showcasing twisting axis loops. Treat with prompt slow IV Magnesium Sulfate push.

C Bedside Safety Screen: Patellar DTR Reflex Testing

Testing the patellar knee-jerk reflex. Disappearance or attenuation of DTRs represents the earliest clinical signal of magnesium toxicity.

Interactive Board MCQ Hub

Q1. A 10-year-old child admitted with severe acute asthma is not responding to back-to-back nebulizations. You plan an IV Magnesium Sulfate infusion. What is its primary physiological mechanism of action in this clinical scenario?

A) Physiological Blockade of L-type Calcium channels leading to bronchodilation. B) Direct beta-2 agonist activation at cellular membranes. C) Antagonism of Muscarinic-3 receptors in bronchial tissue. D) Inhibition of leukotriene pathways.

Q2. What is the clinical gold-standard antidote for managing cardiorespiratory depression secondary to Magnesium toxicity?

A) Intravenous Sodium Bicarbonate (8.4%) B) Intravenous Calcium Gluconate (10%) C) Intravenous Potassium Chloride D) Intravenous Neostigmine

Q3. What is the first clinical sign of Magnesium toxicity that you should monitor for at the bedside?

A) Sudden respiratory arrest B) Flaccid muscle paralysis C) Loss of Deep Tendon Reflexes (DTRs / Knee Jerk) D) Cardiac bradyarrhythmias

Q4. A patient in the PICU exhibits polymorphic Ventricular Tachycardia (Torsades de Pointes). Which drug must be administered as first-line emergency management?

A) Amiodarone Infusion B) Magnesium Sulfate (25-50 mg/kg IV) C) Adenosine rapid push D) Lignocaine bolus

Q5. A preterm baby is being delivered at 30 weeks gestation. Antenatal Magnesium Sulfate is administered to the mother. What is the primary neuroprotective mechanism of action for this fetus?

A) Downregulation of fetal beta-adrenergic receptors B) Blocking NMDA receptors to reduce glutamate-mediated excitotoxicity C) Increasing cerebral perfusion pressure by systemic vasoconstriction D) Induction of fetal surfactant synthesis

Q6. Which of the following pediatric parameters is the most critical to verify before initiating or maintaining a therapeutic Magnesium infusion?

A) Baseline serum calcium levels B) Adequate urine output (>1 mL/kg/hr) to prevent toxic drug accumulation C) Platelet count D) Serum alkaline phosphatase

Q7. An infant in the NICU has persistent hypokalemia that does not resolve despite continuous potassium supplementation. What electrolyte deficiency should you evaluate for next?

A) Hypophosphatemia B) Hypomagnesemia C) Hypernatremia D) Hypercalcemia

Q8. In a resource-limited setting without inhaled Nitric Oxide (iNO), which systemic medication can be initiated to act as a pulmonary vasodilator in Persistent Pulmonary Hypertension of the Newborn (PPHN)?

A) Intravenous Epinephrine B) Intravenous Magnesium Sulfate C) Oral Indomethacin D) Intravenous Phenobarbitone

Q9. What is the standard emergency dose of Magnesium Sulfate recommended for managing status asthmaticus in children?

A) 10 to 15 mg/kg IV bolus B) 100 mg/kg subcutaneous injection C) 25 to 75 mg/kg orally once daily D) 25 to 50 mg/kg (Max 2 grams) IV infused over 20-30 minutes

Q10. A 2-year-old child presents with generalized seizures and is found to have severe hypomagnesemia. If choosing to treat intramuscularly (IM) rather than intravenously, what is the safest concentration of Magnesium Sulfate that can be injected?

A) 50% undiluted injection B) Maximum 20% concentration (dilute 50% solution down with sterile water/NS) C) 1% solution D) Inhaled/nebulized administration only

Quiz Competency Score

0 / 10

Score updates dynamically as you verify answers inside the MCQs Tab.

MgSO₄ Emergency Dosing Engine

Patient Weight (kg)

Clinical Scenario Severe Acute Asthma (50mg/kg) Hypomagnesemia / Seizures (25mg/kg) Torsades de Pointes (25mg/kg)

Target Dose: 750 mg

50% Ampoule Vol: 1.50 mL

Rate: Dilute with 15 mL NS & infused over 20-30 mins.

Critical Reference Values

• Therapeutic: 2.0 - 4.0 mEq/L
• Reflex Loss: 4.0 - 7.0 mEq/L
• Resp. Arrest: 8.0 - 10.0 mEq/L
• Cardio Block: > 12.0 mEq/L